Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
Dendritic cells (DCs) possess the specialized potential to present exogenously derived antigen to cytotoxic T lymphocytes to elicit an immune response. This process, termed cross presentation, is crucial in the generation of immune response to viruses, tumors and in autoimmune disease. The ability o...
Main Authors: | Sachamitr, P, Fairchild, P |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2012
|
פריטים דומים
-
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
מאת: Horton, C, et al.
יצא לאור: (2019) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
מאת: Sachamitr, P, et al.
יצא לאור: (2014) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
מאת: Sachamitr, P, et al.
יצא לאור: (2018) -
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
מאת: Patty eSachamitr, et al.
יצא לאור: (2014-04-01) -
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
מאת: Nguyen Thi Nguyen, et al.
יצא לאור: (2024-12-01)